U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and ...
Pfizer is planning thousands of jobs cuts worldwide as part of a round of cost-cutting as incoming CEO Albert Bourla prepares to take the helm. Bourla has been promoted from his role as chief ...
Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...
Pfizer announced today that it will invest an additional $500 million and add 300 more jobs to increase its newly completed gene therapy manufacturing capabilities at its 230-acre campus in Sanford, ...